The endothelial cell (EC) specific tyrosine kinase receptor, Tie2, interacts with at least two ligands, angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2). Ang1 stimulates Tie2 receptor autophosphorylation, while Ang2 has been reported to inhibit Ang1-induced Tie2 receptor autophosphorylation. We studied the effects of Ang1 and Ang2 in an in vitro model of angiogenesis. Human ECs (HUVEC), cultured on 3-D fibrin matrices, were treated with conditioned media (CM) from stably transfected cells expressing human Ang1 or Ang2, or with purified recombinant proteins. EC tube formation was measured as a differentiation index (DI), calculated as the ratio of total tube length over residual of EC monolayer. CM from Ang1 overexpressing A10 SMC or HEK293T cells induced profound HUVEC differentiation, resulting in the formation of extensive capillary-like tubes within 48 h (DI: 24.5865.91 and 19.1367.86, respectively) vs. control (DI: 2.7361.68 and 2.1561.45, respectively, both P,0.001). Interestingly, CM from two independent cell lines overexpressing Ang2 also produced a significant increase in EC differentiation (DI: 9.2263.00 and 9.7264.84, both P,0.005 vs. control) although the degree of angiogenesis was significantly less then that seen with Ang1. Addition of Ang1* (a genetically engineered variant of naturally occurring Ang1) or Ang2 also resulted in dose dependent increases in DI, which were blocked by an excess of soluble Tie2 receptor (20 3 mg / ml). Both Ang1* and Ang2 induced modest increases in [ H]thymidine incorporation into HUVECs (20 and 26%, respectively), which were inhibited by excess soluble Tie2. Although Ang2 was unable to induce significant Tie2 receptor phosphorylation during a 5-min exposure, a 24-h pretreatment with Ang2, followed by brief re-exposure, produced Tie2 phosphorylation in HUVEC comparable to that produced by Ang1*. These results demonstrate for the first time that Ang2 may have a direct role in stimulating Tie2 receptor signaling and inducing in vitro angiogenesis. Our findings suggest that the physiological role of Ang2 is more complex than previously recognized: acting alternately to promote or blunt Tie2 receptor signaling in endothelial cells, depending on local conditions.
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Introduction
receptors on endothelial cells (ECs) [1] [2] [3] [4] . Central to the angiogenic cascade are the endothelial-specific receptor Angiogenesis is regulated by a delicate balance of tyrosine kinases (RTK) and their respective ligands. Two stimulating and inhibiting factors which bind specific major subfamilies of endothelial-specific RTKs have been described. The vascular endothelial growth factor receptors (VEGFR) were the first to be identified and their role in q This work was presented in part at the 72th Scientific Sessions of the vasculogenesis and angiogenesis has been well established American Heart Association, Atlanta, Georgia, November 1999 [Circula- [1, 2] . The Tie / Tek receptors represent the other EC-spetion 100 (18) cific RTK subfamily consisting of two members, Tie1 and Ang1 may be important in modulating the ability of this Tie2 (or Tek) [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . The ligand(s) for Tie-1 are still ligand to activate its receptor and induce its biological unknown, however, at least two ligands have recently been effects. Alternatively, ECs may be sensitised to respond to identified for Tie2, angiopoietin-1 (Ang1) [19] and angiopoietins in the presence of fibrin matrix, by an angiopoietin-2 (Ang2) [20] .
alteration in their state of activation or by changes in the Tie2 receptors have been implicated in the embryonic expression of other regulatory genes. blood vessel formation. Targeted disruption of the Tie2
In the present study, we tested the ability of Ang1 and gene resulted in an embryonic lethal phenotype between Ang2 to cause EC differentiation in a 3-dimensional fibrin E9.5 and E10.5. [9, 13] . The most prominent defects in matrix model of angiogenesis. We now report that Ang2, these mice included underdevelopment of the endothelial like Ang1 induced extensive capillary-like tube formation lining of the heart, the lack of remodeling of the primary in this model, comparable to that observed with VEGF. capillary plexus to form vessels with higher degrees of Moreover, the angiogenic action of both Ang1 and Ang2 organization and complexity, and the failure of capillary was accompanied by increased Tie2 autophosphorylation, sprouts to invade the developing neuroectoderm. Ang1-which was not modified by growth on fibrin matrices, deficient embryos also exhibited vascular defects, which although this was only observed with Ang2 after prolonged were similar but less marked than those of the Tie2 exposure. knockout animals, with lethality at E12.5, consistent with a critical role of Ang1-Tie2 interaction in vascular development [21] . In contrast, no direct angiogenic role for Ang1 2. Methods was demonstrated initially in models of postnatal vascular tube formation in vivo or in vitro [19, lin (500 U / ml), streptomycin (50 mg / ml) and heparin consistent with the concept that Ang2 may function as an (100 mg / ml) (all from Gibco / BRL, Burlington, ON, endogenous antagonist of Ang1. However, it is possible Canada), and endothelial cell growth factor (ECGF 20 that an important physiological role for Ang2 might be mg / ml, Boehringer Mannheim, Laval, PQ, Canada) and masked by an abnormal spatial or temporal regulation of equilibrated with 95% air and 5% CO at 378C. Cells were 2 expression in these models. In support of this, both Ang1 used between passages 13 and 18. A10 SMC and and Ang2 potentiated VEGF-induced angiogenesis in vivo HEK293T cells were grown in Dulbecco's minimal essenin the mouse corneal micropocket assay, although neither tial medium (DMEM) supplemented with 10% FBS and ligand alone was capable of initiating neovascularization in antibiotics as above. EA.hy926 cells were maintained in this model [22] . Moreover, Ang2 has been shown to DMEM with 10% FBS, as described above, in the presexpress at the forefront of invading neovessels and is ence of 13 HAT (Gibco / BRL). upregulated focally in the endothelium of developing blood vessels in certain tumours [23] [24] [25] and in myocardial 2.2. Generation and use of Ang1 and Ang2 expressing ischemia [26] . cells Although, it has been initially reported that Ang1 failed to induce capillary-like tube formation in collagen matrices Angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2) [19, 27] , Hayes et al. [28] reported that treatment of bovine cDNAs were subcloned into the mammalian expression aortic endothelial cells grown on collagen gels with Ang1 vector pSecTagB / Myc-His(1) (Invitrogen, Mississauga, (100 mg / ml) caused the cells to migrate into the collagen ON) to generate Myc-Histidine epitope-tagged constructs and form capillary-like tubules. Furthermore, it was recent-(Ang1MH and Ang2MH). A portion of Ang1 lacking the ly shown that Ang1 produces sprouting angiogenesis in a leader signal sequence was cloned into SignalpIg-plus fibrin matrix model of in vitro angiogenesis [29] , while the (Novagen, Madison, WI), to generate Ang1Fc as previousactivity of Ang2 was not studied. Given the similarity in ly reported [30] . To produce stable cell lines expressing structure and sequence homology between the anAng1MH and Ang2MH, HEK293T and A10 SMC were giopoietins and fibrinogen, the precursor of fibrin, it is transfected with 10 mg of pSecTagB-Ang1MH or with possible that specific interactions between this matrix and pSecTagB-Ang2MH plasmids. Transfection of HEK293T cells was performed using Lipofectin reagent and OPTIusing a hemocytometer. HUVEC were resuspended in F12 5 MEM medium (both from Gibco / BRL) according to the medium with 15% FBS and plated at a density 5310 manufacture's instructions. A10 SMC were transfected cells / well in six-well plates, either directly on plastic, or using SuperFect Transfection reagent (Qiagen, Missison the surface of the three-dimensional matrix and cultured sauga, ON) according to the manufacturer's recommendafor periods up to 48 h in the presence or absence of study tion. Transfectants were selected in 1 mg / ml zeocin agents as described above. VEGF (10 ng / ml), purchased (Invitrogen) and individual colonies isolated by ring from R&D was used as positive control. cloning, pooled and expanded. To produce Ang1Fc expressing stable cell lines, HEK293T cells were transfected 2.4. Co-culture experiments with 10 mg of SignalpIg-plus-Ang1 using Lipofectin reagent. Transfectants were selected in 1.5 mg / ml G418 Wild type or stably transfected A10 SMC overexpres-(Gibco / BRL) and individual colonies were pooled and sing Ang1 were trypsinized and resuspended in 1% expanded as above. Conditioned medium (CM) was colfibrinogen solution. The fibrinogen-cell mixture was pipetlected during 24 h incubation of the stably transfected cells ted into six-well tissue culture plates, then a-thrombin was in DMEM supplemented in 0.1 or 10% FBS. Ligand added to polymerize the fibrin, as described above. After production was confirmed by RT-PCR and immunopolymerization, cells embedded in the gel were soaked in precipitation with c-Myc antibody (Invitrogen), following cultured medium (DMEM) containing 10% FBS for 2 h. Western analysis. HUVEC were treated for 48 h with CM HUVEC were plated on the surface of the fibrin gel and from either mock-transfected, Ang1MH, Ang1Fc, Ang1Fc-cultured for periods up to 48 h, then examined for depleted or Ang2MH. To deplete Ang1Fc from HEK293T endothelial cell-tube formation, and photographed. CM, 10 ml of media was incubated with 500 ml 20% protein A-Sepharose beads that had been coated with 2.5. Quantitation of endothelial differentiation Tie2-Fc rocked for 12 h. The beads were spun down and the remaining supernatant was applied to HUVEC.
In vitro angiogenesis on fibrin matrices was quantified Human Ang1*, Ang2 and solubleTie2-(s Tie2-Fc) were as previously described [32] . In brief, culture plates kindly provided by Regeneron Pharmaceuticals, Inc., containing HUVEC were assessed after 24-48 h incubaTarrytown, NY [19, 20] . Ang1* and Ang2 recombinant tion under study conditions using an Olympus BX50 proteins were produced as described previously [19] .
inverted microscope (1003). Images were digitized using Ang1* is a genetically engineered variant that retains a Sony CCD-IRIS / RGB camera (Cohu Inc, Tokyo, Japan) properties similar to wild type Ang1. In Ang1*, the nonand analyzed using a computer-assisted morphometric conserved cysteine at residue 245 has been mutated to the analysis system (C Imaging, Compix Inc., Cranberry corresponding serine residue of Ang2, and the first 77 Township, PA) by observers unaware of the culture amino acids of human Ang1 have been replaced with the conditions. Tube-like structures (.30 mm in length) were first 73 residues of Ang2 [20, 31] . The recombinant proidentified and total tube length was derived for each of six teins were prepared in buffer containing 0.05 mol / l Trisrandomly pre-selected fields. At the same time, the total HCl pH 7.5, 150 mmol / l NaCl and 0.05% Chaps. Soluble area of the culture covered by ECs was determined in the Tie2-Fc is a recombinant fusion protein consisting of the same fields. The differentiation index (DI) was calculated ectodomain of the Tie2 receptor fused to the Fc portion of as the ratio of total tube length over cell area for each field human IgG, which was constructed, produced and purified and a mean DI value was obtained for each culture well. as described [19] . Ang1* and Ang2 were used at concentrations from 0 to 2000 ng / ml for 24-48 h. . Endothelial cells were seeded at a density 1-2310 was dissolved in serum free medium and filtered through a cells / well in 24-well plates directly on plastic or in dishes 0.22-mm filter (Millex G.S Millipore, Mississauga, ON).
Quantitation of endothelial cell proliferation

Preparation of fibrin gels
coated with fibrin, in F12 medium supplemented with 15% Fibrin matrices were prepared by polymerizing the fibrino-FCS and were left to adhere overnight. Cells were then gen solution using a low concentration of a-thrombin (2.5 incubated for 24 h in low serum media (2% FBS) prior to U / ml, Sigma) as described before [32] . After polymerithe addition of pure recombinant protein Ang1* or Ang2. zation, gels were soaked in cultured medium containing After a pre-incubation period of 12 h, a tracer amount of 3 15% FBS for 2 h at 378C to inactivate the thrombin.
[ H]thymidine (1 mCi per well; specific activity at 1.85 Confluent endothelial cell cultures were washed with TBq / mmol; Amersham Pharmacia Biotech, Quebec, Hank's buffered saline solution (HBSS) and harvested Canada) was added and the cells were incubated for an using 0.05% trypsin / 0.53 mmol / l EDTA, and counted additional 12 h. Subsequently the cells were washed three times with phosphate-buffered saline (PBS) and DNA was sodium chloride, 1 mmol / l EDTA, 5 mmol / l benzamidine, precipitated with 10% ice-cold trichloroacetic acid (TCA) 1 mmol / l sodium orthovanadate, 10 mg / ml aprotinin, 1 for 20 min. The resulting precipitate was washed with mmol / l PMSF, 10 mg / ml leupeptin, and 1 mg / ml pepice-cold 10% TCA, 95% ethanol, and ethanol / ether (3:1 statin). The lysates were immunoprecipitated with an antiv / v), then air dried. DNA was extracted and solubilized Tie2 antibodies. Immunocomplexes were recovered on with 0.3 mol / l NaOH at room temperature for 20 min, Protein G-Sepharose and separated by SDS-PAGE, transfollowed by neutralization with 0.3 mol / l HCl. Radioacferred to blotting membrane as described above and then tivity was measured in a liquid scintillation counter probed with anti-Tie2, and then with anti-phosphotyrosine (Liquid Scintillation System, Beckman Instrument Inc.
antibodies 4G10 (Upstate Biotechnology, Inc, Lake Placid, Mississauga, ON). Data are expressed as recovered cpm / NY). Monoclonal and polyclonal anti-Tek / Tie2 antibodies well.
specific to the extracellular domain were a kind gift of Fu-Kuen Lin (Amgen, Thousand Oaks, CA). In experi-2.7. Detection of angiopoietins in conditioned media ments with pure proteins, rabbit polyclonal antibody against Tie2 (RG133, Regeneron Pharmaceutical) or comConditioned media was clarified by centrifugation prior mercially available polyclonal antibody against Tie2, (Cto immunoprecipitation. Ang1MH and Ang2MH were 20, Santa Cruz Biotechnology, Santa Cruz, CA) has been precipitated from 10 ml of CM with 2 mg of anti-Myc used. Specific bands were visualized using the ECL system antibody (Invitrogen) and 2 mg of purified rabbit anti-(Amersham Pharmacia Biotech). Densitometry was permouse IgG and recovered using protein A-Sepharose beads formed by scanning the immunoblots (Imaging Densitome-(Pharmacia Biotech, Uppsala, Sweden). The precipitated ter, BioRad) and the intensity of each band was analyzed proteins were eluted in twice-concentrated sodium dodecyl using the Molecular Analyst software (BioRad). sulfate (SDS) sample buffer and boiled for 10 min, separated using SDS-polyacrylamide gel electrophoresis 2.9. Statistical analysis (PAGE) and transferred to PVDF membrane (Novex, Helixx Technologies, Scarborough, ON) using a semi-dry Statistical analysis was performed using the SYS-STAT transfer apparatus (BioRad), according to manufacturer' s software. Significance of differences between groups was instructions. Filters were blocked in 5% non-fat milk in performed using a two-tailed Student's t-test or a one-way TBST buffer ( Fig. 1 shows the Ang2 CM, cells were serum-starved for 6 h, pretreated presence of Ang1 and Ang2 in CM from angiopoietin MH with 1 mmol / l sodium orthovanadate (phosphatase inhiboverexpressing cell lines, detected as a 70-kDa band with itor), pH 8, for 10 min at 378C, and stimulated with 5 ml of aMyc antibodies, whereas Ang1Fc migrated as 97 kDa conditioned medium in the presence of sodium orthovanaprotein in CM from stably transfected HEK293Tcells. date for 10 min. Alternatively HUVEC were maintained overnight in MCDB 131 medium (Gibco / BRL) with 1% 3.2. Effect of angiopoietin-1 overexpressing cells and FBS, and treated with Ang1* or Ang2 recombinant conditioned media on EC differentiation proteins (300 ng / ml each) for 5 min, 1 or 24 h. In some experiments, cells were pre-treated for 24 h in the presence HUVEC grown on fibrin gels in the presence of CM of factors, medium was removed, cells were then serumfrom mock-transfected cells or in co-culture on gels starved in MCDB 131 medium for 2 h, followed by 5 min containing wild type A10 SMCs showed no significant rechallenge with Ang1* or Ang2. After the stimulation, the angiogenic response ( Fig. 2a and c) . However, when cocells were solubilized with RIPA lysis buffer (1% Nonidet cultured with Ang1 overexpressing cells, there was a P-40, 0.5% sodium deoxycholate, 0.1% SDS, 20 mmol / l marked phenotypic change in the endothelial cell monoTris, pH 7.6, 50 mmol / l sodium fluoride, 150 mmol / l layer with the appearance of a network of capillary-like tures (b and c) and the addition of the soluble Tie2 receptor (sTie2, 20 mg / ml) largely prevented EC differentiation in response to both angiopoietins (e and f). The concentration-response relationships for Ang1* and Ang2 are shown in Fig. 5A and B. The recombinant proteins resulted in similar dose dependent increases in EC differentiation index after 24 h which was maximal for both Ang1* and Ang2 at 670 ng / ml, and the magnitude of differentiation was similar for both recombinant proteins. As well, addition of excess soluble Tie2 receptor (20 mg / ml) markedly inhibited endothelial cell differentiation in response to both Ang1* and Ang2. 3 
[ H]Thymidine incorporation in HUVEC
The effect of Ang1* and Ang2 on rates of proliferation of EC cultured on plastic (non-angiogenic) and fibrin (angiogenic condition) are shown in Fig. 6 . In these studies, the proliferation rates of ECs on fibrin was greater than on plastic (23 64161729 vs. 13 63261819 cpm, respectively, P,0.05) In the presence of control medium with 2% FBS, HUVEC demonstrated a relatively high from the mock-transfected cells either in the presence or absence of vanadate (Fig. 7) ; however, Ang1-CM stimuAng2MH produced similar increases in EC differentiation, lated robust tyrosine autophosphorylation of Tie2. These although the magnitude of angiogenic response was less data are in agreement with previous findings establishing a than that seen with Ang1 CM. Media conditioned by role for Ang1 as Tie2 agonist. In contrast, CM from Ang2 Ang1Fc transfected cells produced a response similar to transfected cells did not induce receptor activation at 5 min that observed with Ang1MH (Fig. 3B) . Moreover, deplein EA.hy926 cells cultured on plastic (data not shown), as tion of the Ang1Fc from the CM by protein A-Sepharose, has previously been reported [20] . abolished the angiogenic effect.
The effect of the purified recombinant Ang1* or Ang2 on Tie2 phosphorylation was studied in HUVEC grown on 3.3. Effect of purified recombinant Ang1* and Ang2 on plastic or fibrin (Fig. 8) . Consistent with previous reports, endothelial cell tube formation in fibrin gels Ang1* produced a strong response but Ang2 was unable to induce Tie2 receptor phosphorylation at early time points Representative fields from HUVEC cultured on fibrin (5 min) after ligand addition (panel A). A weak tyrosine matrices in the presence and absence of Ang1* and Ang2 phosphorylation of Tie2 was detected upon stimulation for are shown in Fig. 4 . Both Ang1* and Ang2 (220 ng / ml) 1 h with Ang2. Treatment of EC for 24 h with Ang2 resulted in the formation of extensive capillary-like strucresulted in a robust Ang2-induced phosphorylation of Tie2 (panel C), comparable to that seen in response to Ang1*. tor activation by Ang2 required prolonged exposure to the Similar results were obtained if Tie2 receptor activity was ligand. determined after 24 h of pretreatment with Ang2 followed
The angiopoietins were originally identified by secby washout (2 h) and readdition of Ang2 for 5 min (panel retion-trap and subsequent homology expression cloning, D). Quantitative analysis of Tie2 phosphorylation induced and shown to be specific ligands for the Tie2 receptor by Ang1* or Ang2 is provide in Fig. 9 . Both Ang1* and tyrosine kinase [19, 20] . Targeted disruption of Tie2 in Ang2 revealed significant increase in Tie2 phosphorylation mice resulted in an embryonic lethal phenotype marked by either on fibrin, or plastic (P,0.05 vs. control; by t-test).
abnormalities in vascular remodeling [9, 14] . Unlike the These results clearly demonstrate the ability of Ang2 to targeted disruption of VEGF or Flk-1, in which there was phosphorylate Tie2 in Tie2-expressing endothelial cells failure of endothelial cell differentiation, Tie2-deficient after prolonged exposure.
embryos displayed defects in the later events, including vascular remodeling and stabilization. Disruption of the Ang1 gene produced a nearly identical phenotype as that 4. Discussion of Tie2 receptor knockouts, with embryos exhibiting large vascular channels lacking normal complexity of branching The present study shows that angiopoietin-2 as well and impaired recruitment of pericytes and basement memangiopoietin-1 can promote substantial capillary-like tube brane formation [21] . The Ang2 null phenotype has not yet formation in an in vitro model of angiogenesis. Consistent been described, however, transgenic-overexpression of with these findings, we observed that both ligands induce Ang2 produced an embryonic lethal phenotype generally Tie2 receptor autophosphorylation, although robust recepsimilar to that of Tie2 and Ang1 knockouts [20] . In in vitro that there is an inhibitory mechanism which is EC-specific activity. Each bar represents the mean6S.D. of six experiments. Differ- [20] . Indeed, it is likely that this mechanism also moduence among groups were analyzed by one-way ANOVA followed by the lates the basal level of Tie2 receptor autophosphorylation,
as well as the degree of Ang1-induced phosphorylation [20] . assays, Ang2 has been shown to inhibit Ang1-induced
The remarkable similarity in angiogenic response to Tie2 receptor autophosphorylation, while showing no Ang1 and Ang2 in the present in vitro assay is therefore direct stimulation of receptor phosphorylation by itself.
surprising. Pro-angiogenic actions of Ang2 were seen not These results suggest that Ang2 may be an endogenous only with the conditioned media from two different lines inhibitor of Ang1-induced Tie2 receptor activation [20] .
of Ang2 overexpressing cells, but also with a purified The mechanism by which Ang2 inhibits Ang1-induced recombinant Ang2 protein. Moreover, the inhibition of EC Tie2 receptor autophosphorylation remains poorly undercapillary like tube formation by excess soluble Tie2 stood. It does not appear to be due to an inability of this receptor provides further evidence that Ang2 was acting as ligand to associate with its receptor since Ang2 binds Tie2 a specific agonist of Tie2 in this assay. with an affinity equal to that of Ang1, and can produce
The results of the present study could be explained by a phosphorylation of Tie2 when this receptor is expressed in differential ability of Ang1 and Ang2 to produce homo-Central to an understanding of the mechanism of Ang2-induced effect on EC growth and differentiation is the apparent discrepancy between the biological effects of Ang2 observed in the present study and the previously reported lack of ability of Ang2 to induce Tie2 autophosphorylation [20] . However, Tie2 phosphorylation at early time points after ligand addition may not accurately reflect the activity of this receptor at the later time points, at which EC growth and differentiation are determined. Therefore, we studied the effect of 24-h pre-treatment with either Ang1 or Ang2 on Tie2 phosphorylation under the same conditions used to produce EC differentiation. Prolonged treatment of EC with Ang2 under these conditions resulted in a robust phosphorylation of Tie2 at 24 h. Ang2-induced Tie2 activation could still be observed when the cells were rechallenged with Ang2 2 h after this ligand had been washed out. This novel observation is important since it suggests that the interaction of Ang2 with Tie2 is Tie2 activation, which might release the vascular endothelium from the constitutive homeostatic influence of Ang1 and thus facilitate EC activation, as has previously dimerization of the ligand-receptor, possibly based on been suggested [20, 23, [36] [37] [38] . However, during sustained differences in the molecular characteristics of the anexposure, the effects of Ang2 may progressively shift from giopoietins. The C-terminal portion of these molecules that of an antagonist to an agonist, and at later time points bears a high degree of homology with fibrinogen and other it may contribute directly to vascular tube formation and fibrinogen-like molecules [19, 20, 31] , whereas N-terminal neovessel stabilization, in a manner analogous to Ang1. portion consists of a coiled-coil domain, which is known to Several recent studies have provided support for a be important in oligomerization in a wide variety of permissive role for Ang2 in the angiogenic response [24] . molecular systems [33] . Thus, it is possible that the coiledHolash et al. [37] and others [23, 36] have shown that Ang2 coil domains of the angiopoietins are critical for selfis upregulated in developing glioblastomas in a highly association of these ligands, whereas the fibrinogen-like focal manner, specifically localised to newly formed blood domain appears to be involved in binding to Tie2 [34] . vessels. As well, Ang2 is expressed at the leading edge of Interactions between the angiopoietins and the fibrin vessels invading the corpus luteum [20] . We have recently matrix of the present model system may be important in shown that Ang2 is upregulated following myocardial facilitating angiopoietin self-association in a manner analoinfarction in the rat, particularly in the periinfarct region gous to the role of heparin in facilitating the response to [26] . Moreover, Asahara et al. [22] , have recently demonbFGF [35] . Indeed, an another report demonstrating in strated that both Ang1 and Ang2 significantly potentiated vitro angiogenic actions of Ang1 also utilised fibrin matrix the effect of VEGF in a mouse corneal micropocket assay as the substrate for EC capillary-like tube formation [29] of in vivo angiogenesis, consistent with the synergi and conflicting results exist about Ang1-induced angiobetween VEGF and angiopoietins in vascular development genesis in collagen gels [19, 27, 28] . However, culturing [39] . In this corneal model, both Ang1 and Ang2 induced ECs on fibrin matrix alone induced only weak basal Tie2 the recruitment of perivascular cells (pericytes and SMC), autophosphorylation, and there was no potentiation of and Ang1 produced greater capillary density, whereas, phosphorylation in response to the angiopoietin ligands in Ang2 resulted in greater vessel length. However, direct the presence, compared to the absence, of fibrin. Indeed, intramuscular injection of plasmid DNA encoding Ang1 Ang2 was unable to activate Tie2 in HUVEC grown either but not Ang2 augmented revascularization in the rabbit on fibrin matrix or plastic at an early time point (5 min).
ischemic hindlimb [40] . The difference in the biological Fig. 8 . Phosphorylation of Tie2 receptor by Ang1* and Ang2. HUVEC grown on plastic, or on fibrin matrix, were serum-starved, as described in Methods, and incubated for 5 min (panel A), 1 h (panel B), 24 h (panel C), with pure recombinant proteins (300 ng / ml) or incubated for 24 h with these factors followed by wash out, and incubation with serum free medium for 2 h, and 5 min rechallenge with Ang1* or Ang2 (panel D). Lysates of cells were immunoprecipitated (IP) with anti-Tie2 antibodies and analysed for levels of tyrosine-phosphorylation by immunoblot analysis using anti-phosphotyrosine antibodies as described in Methods. Specific bands were visualized using the ECL system (Amersham Pharmacia Biotech). Similar results were obtained in three experiments.
effects between Ang1 and Ang2 need to be further defined at the molecular and cellular level. Clearly the effects of angiopoietins on proliferation were relatively modest. It is quite possible that there were competing proliferative (i.e. activation) and antiproliferative (i.e. differentiating) actions, and that higher concentrations the latter may have predominated. For example, Tie2 activation has been reported to inhibit EC apoptosis via Akt / PI3 kinase [41, 42] . This same pathway is known to activate eNOS by serine phosphorylation [43] , and we have previously shown that NO can inhibit HUVEC proliferation [32] . This might also explain the difference between Ang1 and Ang2, since the delay in receptor activation may have slightly favoured proliferation at Fig. 9 . Quantitative analysis of Tie2 phosphorylation induced by Ang1* higher concentrations. It is unlikely that these proliferative or Ang2. Experiments were performed as described in Fig. 8 (panel D) .
actions of angiopoietins would play much of a role, rather Densitometry was performed by scanning the autoradiographs, and the their much stronger effects of EC differentiation, and intensity of each band was analyzed using Molecular Analyst (BioRad). vascular maturation would be of much greater importance.
Bars represent mean6S.D. from three separate experiments. The differThus, these findings provide the first demonstration that ence between each individual group were evaluated by Student's t-test. 
